Viewing Study NCT03111992

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 3:15 PM
Ignite Modification Date: 2026-03-08 @ 1:50 AM
Study NCT ID: NCT03111992
Status: COMPLETED
Last Update Posted: 2022-02-09
First Post: 2017-03-22
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Study of Single Agent CJM112, and PDR001 in Combination With LCL161 or CJM112 in Patients With Multiple Myeloma
Sponsor: Novartis Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Multiple Myeloma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Myeloma, View
None Multiple Myeloma, View
None Hematologic Diseases, View
None Myeloma, Multiple, View
None Myeloma-Multiple, View
None Programmed Cell Death 1 Receptor View